Market intelligence
STLNSector not reported
Starling Oncology, Inc. insider activity
In the last 90 days, 1 corporate insider purchased $78,480 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $78,480
- Corporate buyers
- 1
- Latest transaction
- Aug 21, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
